Who is an expert in ras-specific pancreatic cancer trials

According to the National Cancer Institute (NCI), several leading institutions and researchers are at the forefront of RAS-targeted therapy in pancreatic cancer:

1. The NCI's RAS Initiative highlights Dr. [removed] McCormick at UCSF Helen Diller Family Comprehensive Cancer Center as a leading expert in RAS-targeted therapies.

2. According to ASCO (American Society of Clinical Oncology) guidelines and research programs, key centers conducting RAS-specific trials include:

• Memorial Sloan Kettering Cancer Center
• MD Anderson Cancer Center
• Dana-Farber Cancer Institute
• Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

The NCCN (National Comprehensive Cancer Network) Guidelines recommend that patients with KRAS mutations consider participating in clinical trials at major cancer centers, as approximately 95% of pancreatic cancers have KRAS mutations.

I recommend:

1. Discussing RAS-specific trial options with your oncologist
2. Visiting clinicaltrials.gov to search for current RAS-targeted trials
3. Contacting the major cancer centers listed above about their RAS-specific research programs

Would you like me to provide more specific information about current RAS-targeted clinical trials or help you locate the nearest major cancer center conducting these trials?

Remember: Your oncologist can help determine if you're eligible for specific trials and can make appropriate referrals to these experts and centers.